Minireviews
Copyright ©The Author(s) 2021.
World J Stem Cells. Sep 26, 2021; 13(9): 1278-1292
Published online Sep 26, 2021. doi: 10.4252/wjsc.v13.i9.1278
Table 2 Therapeutic potentials of stem cell transplantation in Parkinson's disease models

Disease model
Source of transplanted cells
Transplantation location
Density of transplanted cells
Unique feature or treatment
Results
Ref.
1Rat, 6-OHDAImmortalized NSC (mouse, C17-2)Striatum106 cellsTH/GTPCH1; Gene transferRotation↓Ryu et al[48]
2Monkey, MPTP ESC (monkey)Bilateral putamen3 x 105-6 x 105 cells per sideStromal cell (mouse) feederPFS-parkinsonian factor score↓Takagi et al[49]
3Rat, 6-OHDA Immortalized NSC (human, HB1.F3)Striatum3 × 105 cells/3 μLTH/GTPCH1 gene transferRotation↓Kim et al[50]
4Rat, 6-OHDA Immortalized NSC (human, HB1.F3)Striatum2 x 105/3µLNSC migration Rotation↓Yasuhara et al[51]
5Rat, 6-OHDAMSCs from human UCBStriatum1 × 105 cells/10 µLFGF8/SHH Rotation↓Fu et al[52]
6Rat, 6-OHDA DA neurons from ESC (human)Striatum5 x 105 cellsNone Rotation↓, beam walking↓Cho et al[53]
7Mice, 6-OHDA DA neurons from ESC (human)Striatum1.5 × 105 cells /1.5 µLWnt signal; SHHRotation↓Kriks et al[54]
8Mice, 6-OHDA iNSCs (rat)Striatum1 × 105 cellsTripotential differentiation capacityRotation↓Choi et al[42]